B O O K - American College of Rheumatology

ACR/ARHP Poster Session C
1804. Effects of Subcutaneous and Intravenous Golimumab on
Markers of Inflammation in Patients with Rheumatoid
Arthritis. Mittie K. Doyle 4 , Mahboob U. Rahman 4 , Bart
Frederick 2 , Charles A. Birbara 6 , Dick de Vries 1 , Gary Toedter 3 ,
Xiaoying Wu 3 , Dion Chen 2 , Mark Westerman 5 and Daniel E.
Furst 7 , 1 Centocor B.V., Leiden, The Netherlands, 2 Centocor
Research and Development, Inc., Malvern, PA, 3 Centocor
Research and Development, Inc., 4 Centocor Research and
Development, Inc./Univ. of Pennsylvania School of Medicine,
Malvern, PA, 5 Intrinsic Life Sciences, 6 Univ. of Massachusetts City
Campus, Worcester, MA, 7 University of California Los Angeles
Medical School, Los Angeles, CA.
1805. Efficacy and Safety of Certolizumab Pegol in a Clinically
Representative Population of Patients (Pts) with Active
Rheumatoid Arthritis (RA): Results of the REALISTIC Phase
IIIb Randomized Controlled Study. Michael Weinblatt 2 , Roy
Fleischmann 8 , Paul Emery 3 , Niti Goel 11 , Clifton O. Bingham 5 ,
Janet Pope 9 , Elena Massarotti 1 , Ronald van Vollenhoven 6 ,
Thomas W. J. Huizinga 7 , Benjamin Duncan 10 and Maxime
Dougados 4 , 1 Brigham and Women’s Hospital, Boston, MA,
2
Brigham and Women’s Hospital, 3 Chapel Allerton Hospital,
Leeds, United Kingdom, 4 Hospital Cochin, Paris, France, 5 Johns
Hopkins University, Baltimore, MD, 6 Karolinska Institute,
Stockholm, Sweden, 7 Leiden University Medical Centre, Leiden,
The Netherlands, 8 MCRC, University of Texas, Dallas, TX, 9 St.
Joseph’s Health Care, University of Western Ontario, London,
ON, Canada, 10 UCB, Raleigh, NC, 11 UCB, Smyrna, GA.
1806. Efficacy and Safety of Certolizumab Pegol Plus Methotrexate
in Patients with Rheumatoid Arthritis (RA): 3-Year Data
from the RAPID 2 Study. Josef S. Smolen 4 , Ronald F. van
Vollenhoven 1 , Arthur Kavanaugh 8 , Niti Goel 7 , Andreas
Fichtner 6 , Vibeke Strand 3 , Jiri Vencovsky 5 and Desiree van der
Heijde 2 , 1 Department of Rheumatology, Karolinska Institute,
Stockholm, Sweden, 2 Department of Rheumatology, Leiden
University Medical Center, Leiden University Medical Center,
Leiden, Meerssen, The Netherlands, 3 Division of Immunology
and Rheumatology, Stanford University School of Medicine,
Palo Alto, CA, 4 Division of Rheumatology, Medical University
of Vienna and Hietzing Hospital, Vienna, Austria, 5 Institute
of Rheumatology, Prague, Czech Republic, 6 UCB, Monheim,
Germany, 7 UCB, Smyma, GA, 8 University of California-San Diego,
La Jolla, CA.
1807. Efficacy and Safety of Rituximab Treatment in Clinical
Practice: Data from the CERERRA Collaboration. Katerina
Chatzidionysiou 10 , Elisabeth Lie 5 , Galina Lukina 8 , Merete L.
Hetland 3 , Ulrik Tarp 2 , Cem Gabay 12 , Piet L. Van Riel 14 , Dan C.
Nordström 11 , Juan J. Gomez-Reino 6 , Karel Pavelka 1 , Matija
Tomsic 13 , Evgeny L. Nasonov 7 , Tore K. Kvien 4 and Ronald Van
Vollenhoven 9 , 1 Charles Univ, Prague, 2 DANBIO, Univ Hosp,
Copenhagen, Denmark, 3 DANBIO, Univ Hosp, Copenhagen,
Denmark, 4 Diakonhjemmet Hospital, Oslo, Norway,
5
Diakonhjemmet Hospital, Oslo, Norway, 6 Hospital Clinico
Universitario, Santiago, Spain, 7 Institue of Rheumatology,
Moscow, Russian Federation, 8 Institute of Rheumatology,
Moscow, 9 Karolinska University Hospital, Stockholm, Sweden,
10
Karolinska University Hospital, Stockholm, 11 ROB-FIN Univ
Hosp, Helsinki, 12 Univ Hosp of Geneva, Geneva, Switzerland,
13
Univ Med Center, Ljubljana, 14 University Hosp Nijmegen,
Nijmegen, The Netherlands.
1808. Efficacy and Safety of Tocilizumab in Patients with Moderate
to Severe Active RA and a Previous Inadequate Response
to DMARDs: The ROSE Study. Yusuf Yazici 3 , Jeffrey R. Curtis 6 ,
Akgun Ince 4 , Herbert Baraf 5 , Raymond L. Malamet 1 , Carol Y.
Chung 2 and Arthur Kavanaugh 7 , 1 Genentech, a Member of
the Roche Group, South San Francisco, South San Francisco,
CA, 2 Genentech, a Member of the Roche Group, South San
Francisco, CA, 3 NYU Hospital for Joint Diseases, New York,
NY, 4 St. Louis University School of Medicine, St. Louis, MO,
5
The Center for Rheumatology and Bone Research, Wheaton,
Wheaton, MD, 6 University of Alabama at Birmingham,
Birmingham, AL, 7 University of California at San Diego, La Jolla,
CA.
1809. Efficacy of Abatacept and Tocilizumab in Rheumatoid
Arthritis Patients Treated in Clinical Practice. Results from
the Nationwide Danish DANBIO Registry. Henrik C. Leffers 4 ,
Mikkel Ostergaard 4 , Bente Glintborg 7 , Niels Steen Krogh 10 , Heidi
Foged 6 , Ulrik Tarp 1 , Tove Lorenzen 9 , Annette Hansen 3 , Michael
S. Hansen 2 , Martin S. Jacobsen 8 and Merete L. Hetland 5 , 1 Aarhus
University Hospital, Denmark, 2 Copenhagen University Hospital
Gentofte, Denmark, 3 DANBIO Registry, and Copenhagen
University Hospital Gentofte, Denmark, 4 DANBIO Registry,
and Copenhagen University Hospital, Hvidovre and Glostrup,
Hvidovre, Denmark, 5 DANBIO Registry, and Copenhagen
University Hospital, Hvidovre and Glostrup, Denmark,
6
Frederiksberg Hospital, Denmark, 7 Holbæk Hospital, Denmark,
8
Randers Hospital, Denmark, 9 Vejle Hospital, Denmark, 10 Zitelab
Aps, Denmark.
1810. Efficacy of Rituximab on Pulmonary Rheumatoid Nodules:
Data of 10 Patients from the French AIR/PR Registry. Baptiste
Glace 7 , Jacques E. Gottenberg 13 , Xavier Mariette 1 , Antoine
Roche 5 , Jean-Marie Berthelot 11 , Maxime Dougados 3 , Eric
Toussirot 6 , Thao Pham 9 , Yannick Allanore 2 , Damien Loeuille 10 ,
Liana E. Euller-Ziegler 4 , Thierry Lequerré 12 and Martin Soubrier 8 ,
1
Bicetre Hospital/Paris Univ, Le Kremlin Bicetre, France,
2
Hopitaux de Paris Cochin, Paris, France, 3 Hospital Cochin,
Paris, France, 4 L’Archet Hospital (University), Nice, France,
5
Radiology Department, CHU Clermont-Ferrand, 6 Rheumatology
Department, CHU Besançon, 7 Rheumatology Department,
CHU Clermont-Ferrand, 8 Rheumatology Department, CHU
Clermont-Ferrand, 9 Rheumatology Department, CHU Marseille,
10
Rheumatology Department, CHU Nancy, 11 Rheumatology
Department, CHU Nantes, 12 Rheumatology Department, CHU
Rouen, 13 Strasbourg Hospitals, Strasbourg, France.
1811. Etanar® Therapy in Real-Life Patients with Rheumatoid
Arthritis. Federico Rondon 11 , Alain Bautista 4 , Juan Carlos
Salazar 1 , Nohemí Casas 9 , Pedro Santos 9 , Francisco Vargas 6 , Javier
Márquez 2 , Fredy Pumarejo 8 , Fernando Fernández 3 , Andrés
Fernández 5 , Rossana Mejía 1 , Oscar Ruiz 1 , Alberto Torrenegra 3 ,
Jose Bernardo Martínez 7 and Rubén Darío Mantilla 10 , 1 CIREI,
Bogota, 2 Hospital Pablo Tobon Uribe, Medellin, 3 Rheumatology,
Barranquilla, 4 Rheumatology, Cucuta, 5 Rheumatology,
Ibague, 6 Rheumatology, Medellin, 7 Rheumatology, Monteria,
8
Rheumatology, Valledupar, 9 Riesgo de Fractura-CAYRE IPS,
Bogota, 10 Riesgo de Fractura-CAYRE IPS, Bogota, Colombia,
11
Universidad Nacional, Bogota.
2010 Program Book 259